findmyKOL
Clinical trialNCT04646226Active, not recruitingInterventional

The Arteriovenous Vascular (AV) ACCESS Trial

SponsorWake Forest University Health SciencesEnrollment103End-Stage Kidney DiseaseHemodialysis Complication
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study is to prospectively compare the effectiveness and safety of the two types of arteriovenous access placement (fistula or graft) in older adults with end stage kidney disease and multiple chronic conditions
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Alabama at Birmingham School of Medicine

    Birmingham, Alabama, United States

  • Ucla

    Los Angeles, California, United States

  • Johns Hopkins School of Medicine

    Baltimore, Maryland, United States

  • Atrium Wake Forest Baptist Medical Center

    Winston-Salem, North Carolina, United States

  • Prisma Health Upstate

    Greenville, South Carolina, United States

  • University of Tennessee Medical Center at Knoxville

    Knoxville, Tennessee, United States

  • University of Wisconsin School of Medicine and Public Health

    Madison, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
18 Aug 2022
Primary completion
30 Jun 2027
Completion
31 Aug 2027
Last update posted
1 Jun 2026
Registered enrollment
103
Registry id
NCT04646226
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.